Abstract Human β-1,4-galactosyltransferase (β-1,4-GalT) V was shown to be involved in the biosynthesis of N-glycans, O-glycans and lactosylceramide (Lac-Cer) by in vitro studies. To determine its substrate specificity, enzymatic activity and its products were analyzed using mouse embryonic fibroblast (MEF) cells from β-1,4-GalT V (B4galt5)-mutant mice. Analysis of expression levels of the β-1,4-GalT I-VI genes revealed that the expression of the β-1,4-GalT V gene in 
Introduction
It is well known that glycans attached to proteins and lipids at cell surfaces are involved in cell-to-cell and cell-to-matrix interactions, thus inducing embryonic development, growth and differentiation [2] [3] [4] [5] [6] . In fact, such biological events are often hampered by impairments of glycosylation of proteins and lipids [7-16 and reviewed in 17] . The β-1,4-galactosylation of N-and O-glycans is particularly important for biological events since many functional carbohydrate antigens such as polysialic acids, HNK-1 antigen, sialyl Lewis X antigen, and Lewis X and Y antigens are expressed soley on the galactose (Gal) residues [reviewed in 18] . On the other hand, the β-1,4-galactosylation of glucosylceramide (Glc-Cer) opens diverse biosynthetic pathways of glycosphingolipids (GSLs) such as ganglio-, lacto-, neolacto-, globo-and isoglobo-series [reviewed in 19] . There are six β-1,4-galactosyltransferases (β-1,4-GalTs) I, II, III, IV, V and VI [reviewed in 20] , which are supposed to be involved in the biosyntheses of N-and O-glycans attached to proteins [21, 22] and of glycans attached to sphingolipids [23] [24] [25] . However, their exact acceptor specificities have not been established. Expression of individual human β-1,4-GalT cDNAs in Sf-9 cells, which lack a β-1,4-GalT activity and express Nacetylglucosamine (GlcNAc)-terminating N-glycans [26] , resulted in the galactosylation of proteins as revealed by lectin blot analysis using Ricinus communis agglutinin-I (RCA-I), which interacts with oligosaccharides terminated with the Galβ1→4GlcNAc/Glc group [27] , suggesting that all β-1,4-GalTs can galactosylate N-glycans in Sf-9 cells [28] .
We isolated the β-1,4-GalT V cDNAs from human breast cancer cells [21] and mouse brain [29] , and showed it to be involved in the biosyntheses of N-glycans, O-glycans, and lactosylceramide (Lac-Cer) by in vitro studies [21, 22, 28, 30] . In the previous study, we analyzed the phenotypes of the β-1,4-GalT V-mutant (B4galt5 −/− ) mice raised by a gene trap method, and showed that B4galt5 −/− mice can grow up to E10.5 [14] . However, due to limited amounts of proteins available from B4galt5 −/− -mouse embryos for biochemical studies, analyses of acceptor specificities of β-1,4-GalT V and structures of their glycans attached to proteins and sphingolipids were hardly conducted. In the present study, we isolated fibroblast cells from B4galt5 +/+ -, B4galt5 +/− -and B4galt5 −/− -mouse embryos for elucidation of acceptor specificity of β-1,4-GalT V and their structures of N-glycans attached to proteins and of glycans attached to sphingolipids. The results showed that murine β-1,4-GalT V is involved in Lac-Cer biosynthesis like human β-1,4-GalT V as we reported by in vitro study 10 years ago [30] .
Materials and methods

Chemicals
Glucosylceramide (Glc-Cer), Lac-Cer, GM3, sphingomyelin (SM) and UDP-Gal were purchased from Sigma-Aldrich 
Isolation of mouse embryonic fibroblast (MEF) cells
B4galt5
−/− -mouse embryos were obtained as described previously [14] . MEF cells were isolated from B4galt5 +/+ -, B4galt5 +/− -and B4galt5 −/− -mouse embryos at E10.5, and cultured in Dulbecco's modified Eagle's medium containing 15% fetal calf serum, 50 units/ml penicillin and 50 μg/ ml streptomycin at 37°C under a 5% CO 2 condition. The genotypes of the MEF cells were determined by PCR according to the method described previously [14] . All experiments were conducted according to institutional ethical guidelines for animal experiments and safety guidelines for gene manipulation experiments.
RT-PCR analysis
The expression of the mouse β-1,4-GalT I-VI genes was analyzed by reverse transcription-polymerase chain reaction (RT-PCR) using a Quick Master Mix (Toyobo Co., Ltd., Osaka) according to the manufacturer's instructions. In brief, total RNA preparations were obtained from MEF cells using a Sepasol RNA I total RNA isolation reagent (Nacalai Tesque Inc., Kyoto). RT-PCR analysis was conducted using total RNAs and oligonucleotide primers specific to the mouse β-1,4-GalT I-VI genes. Their nucleotide sequences of the forward and reverse primers for the β-1,4-GalT I-VI genes and elongation factor (EF) 1α gene used are described in Table 1 . Conditions for RT-PCR were as follows: one cycle at 90°C for 30 s; 60°C for 30 min; 94°C for 1 min, and then 26 cycles at 94°C for 30 s, 60°C for 30 s and 72°C for 1 min. The PCR products were analyzed by agarose gel electrophoresis as described previously [14] Fig. 1, 2 .
Characterization of PA-oligosaccharides from MEF cells by two-dimensional mapping analysis
Membrane protein samples (2 mg) prepared from MEF cells were dried thoroughly over P 2 O 5 in vacuo, and subjected to hydrazinolysis at 100°C for 10 h as described previously [31] . After N-acetylation, liberated oligosaccharides were reduced with dimethylamino borane in the presence of 2-aminopyridine (PA) to obtain pyridylaminated (PA)-oligosaccharides [32] . After desialylation of PAoligosaccharides with 25 mM HCl solution at 80°C for 1 h, PA-oligosaccharides were subjected to two-dimensional mapping analysis as described previously [33] . In brief, PA-oligosaccharides were separated by size-fractionation high performance liquid chromatography (HPLC) on a TSK gel Amide-80 column with ammonium formate/acetonitrile gradient solution. Elution positions of PA-isomaltooligosaccharides with 1-15 glucose units (GUs) were shown at the top of each panels in Fig. 3A . Then, oligosaccharides separated into 11 fractions were further separated by reversed-phase HPLC on a Cosmosil 5C18-P column with triethylamine acetate/1-butanol gradient solution. In order to characterize individual oligosaccharides separated by two-dimensional mapping analysis, retention times of individual oligosaccharide peaks separated into 21 components on a Cosmosil 5C18-P column as shown in Fig. 3B were converted to reversed-phase scales. Thus, a given oligosaccharide from these two columns can obtain a set of GU-value and reversed-phase scale, which affords a unique co-ordinate on the two-dimensional map. Relative peak areas of individual PA-oligosaccharides were calculated by taking a maximum peak area of one of PAoligosaccharides in each sample as 100%, and then relative amounts of other PA-oligosaccharides were expressed as dot-sizes. In the present study, peaks 11 were maximal in all three samples, and their areas were taken as 100%.
Assays of β-1,4-GalT activities MEF cells harvested were washed with 10 mM phosphate buffered saline (pH 7.4) (PBS) by three times and suspended in 100 mM 2-(N-morpholino)ethansulfonic acid (MES) buffer (pH 7.0) containing 1.25% Triton X-100. They were sonicated and cell homogenates were used for transferase assays as an enzyme source. β-1,4-GalT assays were performed as described previously [21] . The reaction mixture contained 100 mM MES buffer (pH 7.0) containing 4 mM 5′-AMP, 250 μM UDP-[ 3 H]Gal, 1 mM GlcNAcβ-SpNP, 20 mM MnCl 2 and enzyme preparation in a total volume of 50 μl. After incubation at 37°C for 1 h, product was isolated by using Sep-Pak C 18 cartridges (Waters Corp., Milford, MA) and radioactivity incorporated into product was determined. Assay for Lac-Cer synthase activity was performed as described previously [30] . The reaction mixture contained 100 mM MES buffer (pH 7.0) containing 4 mM 5′-AMP, 250 μM UDP-
EF1α-F CCATGAAGCTTTGAGTGAAGCTCT EF1α-R TAGCCTTCTGAGCTTTCTGGGCAG Glc-Cer, 20 mM MnCl 2 , and enzyme preparation in a total volume of 50 μl. After incubation, glycolipid was extracted from the reaction mixture with chloroform:methanol (2:1, v/v) by three times and then subjected to thin-layer chromatography (TLC) together with Lac-Cer, Glc-Cer and SM as standards in a developing solvent containing chloroform:methanol:water (60:35:8, v/v). Glycolipids were detected with an anthrone-thiourea reagent by heating the plate at 120°C. The areas corresponding to Lac-Cer in each sample were excised, and glycolipid was extracted. Radioactivities incorporated were determined by liquid scintillation counter.
Analyses of glycoproteins and glycolipids
MEF cells were washed with PBS by three times. Membrane proteins prepared from cells were subjected to SDS-polyacrylamide gel electrophoresis, and proteins were transferred to polyvinylidene difluoride filters. The blotted filters were incubated with SNA, MAA, Con A, RCA-I, L-PHA and PNA according to the method described previously [34] . Protein concentrations of cell pellets were determined with a BCA kit (Pierce Co., Rockford, IL) using bovine serum albumin as a standard, and glycolipids were analyzed by the method described previously [35] . In brief, total lipid fraction was extracted from cells with chloroform:methanol:water (1:2:0.8, v/v), and centrifuged at 12,000 rpm for 5 min. The supernatant containing lipids was dried by centrifugation using a SpeedVac concentrator (Savant Instruments Inc., Farmingdale, NY). Lipid samples were subjected to mild alkaline hydrolysis with 0.1 M NaOH/methanol solution at 40°C for 1 h, and then neutralized with 1 M acetic acid/methanol solution. For neutral glycolipid analysis, lipid samples whose amounts equivalent to 700 μg of cellular proteins were subjected to TLC using a high-performance TLC silica gel 60 plate (Merck KGaA, Darmstadt, Germany). The plate was developed in a solvent containing chloroform:methanol: water (60:25:4, v/v), and stained with an anthrone-thiourea reagent by heating at 120°C for detecting neutral glycolipids. In the case of gangliosides, lipid samples whose amounts equivalent to 350 μg of cellular proteins were subjected to TLC as described before. The plate was developed in a solvent containing chloroform:methanol:0.5% CaCl 2 (11:9:2, v/v), and stained with a resorcinol-HCl reagent by heating at 120°C for detecting gangliosides. Ratios of individual GSL components were determined by densitometric analysis. Furthermore, neutral glycolipid fractions were subjected to electrospray ionization linear-ion-trap mass spectrometric analysis as described previously [36] .
Results
Expression of β-1,4-GalT I-VI genes in MEF cells
The expression of the β-1,4-GalT V gene among B4galt5 RT-PCR analysis was carried out using total RNAs from each cell preparations and oligonucleotide primers specific to the β-1,4-GalT gene to be analyzed (shown in Table 1 ). PCR products were detected in a 2% agarose gel by staining with ethidium bromide. EF1α was used as an internal control. The analysis was conducted three times, and identical results were obtained mice affected the expression of several other glycosyltransferase genes [37] , the expression levels of the β-1,4-GalT I, II, III, IV and VI genes were examined by RT-PCR. The results showed that no significant changes in their expression levels are observed among three samples (Fig. 1-β-1,4 -GalTs I, II, III, IV and VI, respectively).
Proliferation kinetics of MEF cells
In order to examine whether or not growth of the MEF cells changes by the gene-ablation, proliferation kinetics of cells were studied by determining cell numbers of B4galt5 +/+ -, B4galt5 +/− -and B4galt5 −/− -derived MEF cells with a Coulter counter. The results showed that proliferation kinetics of the MEF cells are relatively similar among three samples (Fig. 2) , indicating that growth of B4galt5 −/− -derived MEF cells is not affected by the gene-ablation.
Structural analysis of N-glycans from MEF cells by two-dimensional mapping method
Our previous studies showed that β-1,4-GalT V can be involved in the galactosylation of N-glycans in addition to the galactosylation of Glc-Cer [21, 28, 30] . Therefore, it was important to characterize structures of N-glycans, particularly galactosylated complex-type oligosaccharides. To conduct this, N-glycans were released from membrane protein samples of B4galt5 -derived MEF cells by hydrazinolysis, and then pyridylaminated. Then, they were treated with mild acid to convert acidic PAoligosaccharides to neutral ones [38] , and subjected to HPLC using two different columns [33] . Size-fractionation column chromatography using an amide column showed that PAoligosaccharides from three samples are separated into 11 fractions as indicated below individual peaks in Fig. 3A panels a, b and c, respectively, and amounts of individual peaks are relatively constant among three samples (Fig. 3A) . PA-oligosaccharides in individual peaks obtained in Fig. 3A were further separated by reversed-phase HPLC, and similar retardation profiles of PA-oligosaccharides were obtained from three samples (Fig. 3B panels a, b and c, respectively) . The positions of individual PA-oligosaccharides fractionated on each column were plotted as dots whose sizes were proportional to their amounts on the two-dimensional map as determined by two-dimensional mapping method [33] . In this analysis, dots 6, 7 and 8 represent mono-galactosylated bi-antennary complex-type oligosaccharides, dots 10, 11 and 12 di-galactosylated bi-antennary ones, and dots 16 and 17 tri-galactosylated tri-antennary ones. Since sizes of most dots described above were relatively constant among three samples (Fig. 3C) , amounts of individual galactosylated complex-type oligosaccharides are not changed significantly by the ablation of the β-1,4-GalT V gene in mouse. Dots 1, 2, 3 and 4 represent ungalactosylated bi-antennary complextype and hybrid-type oligosaccharides. Dots 1 and 2 were detected in B4galt5 +/− -derived MEF cells (Fig. 3C panel b) but not in B4galt5 +/+ -and B4galt5 −/− -derived MEF cells (Fig. 3C panels a and c) . Dot 21 represents monoglucosylated high mannose-type oligosaccharides, and was detected in B4galt5 +/− -and B4galt5 −/− -derived MEF cells (Fig. 3C panels b and c) but not in B4galt5 +/+ -derived MEF cells (Fig. 3C panel a) . These minor changes of N-glycan components among three samples could be due to slight differences in their genetic backgrounds. Furthermore, the sizes of dots 18 and 20 in the B4galt5 −/− -derived MEF cell sample (Fig. 3C panel c) subjected to lectin blot analysis using SNA and MAA lectins that bind sialylated oligosaccharides since most sialylation occurs to penultimate galactose residues. Membrane glycoprotein samples were subjected to SDS-polyacrylamide gel electrophoresis, and proteins were transferred to polyvinylidene difluoride filters. When the blotted filters were stained with Coomassie Brilliant Blue (CBB), three samples showed similar protein components (Fig. 4-CBB) . No significant changes in binding of glycoprotein samples to SNA, which interacts with oligosaccharides terminated with the Neu5Acα2→ 6Gal residue [39] (Fig. 4-SNA) and to MAA, which interacts with oligosaccharides terminated with the Neu5Acα2→3Gal residue [40] (Fig. 4-MAA) , were observed among three samples, indicating no significant change in the sialylation, which reflects no change of the galactosylation of N-glycans in B4galt5 -derived MEF cells. Furthermore, no significant changes in bindings of glycoprotein samples to Con A, which interacts mainly with high mannose-type oligosaccharides [41] (Fig. 4-Con A) , to RCA-I, which interacts with oligosaccharides terminated with the Galβ1→4GlcNAc/Glc group [27] (Fig. 4-RCA-I) , and to L-PHA, which interacts with highly branched N-glycans [42] (Fig. 4-L-PHA) , were obtained from three samples. These results indicate that the ablation of the β-1,4-GalT V gene does not affect the apparent glycosylation patterns including the galactosylation of N-glycans of the MEF cells.
Since our previous study also showed that human β-1,4-GalT V can galactosylate O-glycans [22] , we initially examined whether or not O-glycans are expressed on MEF cells by lectin blot analysis using PNA which interacts with the Galβ1→3GalNAc group on O-glycans [43] . The results showed that a few protein bands with relatively higher molecular weight react weakly with PNA in all samples from B4galt5 +/+ -, B4galt5 +/− -and B4galt5 −/− -derived MEF cells (Fig. 4-PNA) , indicating that MEF cells produce only a small amount of O-glycans when compared with that of N-glycans, and it is hard to examine changes if any in the galactosylation of O-glycans among three genetically different samples.
Determination of β-1,4-GalT activities towards GlcNAcβ-S-pNP and Glc-Cer
Our previous studies showed that recombinant human β-1,4-GalT V possesses an activity towards GlcNAcβ-S-pNP [21] , and also a relatively higher activity towards Glc-Cer than human β-1,4-GalT VI [30] . When cell homogenates as an enzyme source were incubated with GlcNAcβ-S-pNP in the presence of UDP-[ 3 H]Gal, 5.1±0.7, 4.6±0.2 and 6.0± 0.5 nmol Gal-transferred/mg protein/h were obtained from B4galt5 +/+ -, B4galt5 +/− -and B4galt5 −/− -derived MEF cells, respectively, (Fig. 5A) , indicating no significant difference in the activity among three samples. However, when they were incubated with Glc-Cer in the presence of UDP- -derived MEF cells (Fig. 5B) . These results indicate that β-1,4-GalT V is involved in Lac-Cer synthesis and that the residual activity found in B4galt5 −/− -derived MEF cells could be due to β-1,4-GalT VI, originally isolated as a Lac-Cer synthase [25] , as expressed in the MEF cells (Fig. 1-β-1,4 -GalT VI lane c).
Determination of glycolipid components in MEF cells
To examine whether or not glycolipid components changed by the ablation of the β-1,4-GalT V gene, total lipid fractions were prepared from B4galt5 (Fig. 6A) . Similar results were obtained by electrospray ionization linear-ion-trap mass spectrometric analysis (data not shown). There were three major bands detected below Lac-Cer on a TLC plate in all samples (Fig. 6A) , and positions of two of them coincided with those Since Lac-Cer is a precursor molecule for gangliosides [19] , it was of interest to investigate whether or not components of gangliosides also changed by the ablation of the β-1,4-GalT V gene. Acidic glycolipid fractions were prepared from three samples and subjected to TLC analysis. When gangliosides on TLC plates were detected with a resorcinol-HCl reagent, amounts of GM3, which is sialylated Lac-Cer, in samples from B4galt5 +/− -and B4galt5 −/− -derived MEF cells decreased to 42% and 12%, respectively, of that from B4galt5 +/+ -derived MEF cells as determined by densitometric analysis (Fig. 6B) . These results strongly indicate that murine β-1,4-GalT V is involved in the biosynthesis of Lac-Cer.
Discussion
The present study shows that murine β-1,4-GalT V is involved in Lac-Cer biosynthesis and appears not to be involved in the galactosylation of N-glycans. About 90% of Lac-Cer synthase activity was lost in B4galt5 −/− -derived
MEF cells when compared with B4galt5
+/+ -derived MEF cells. The residual 10% of the activity found in B4galt5 −/− -derived MEF cells could be due to activityies of β-1,4-GalT VI expressed, which was initially isolated from rat brain as a Lac-Cer synthase [25] , and/or of β-1,4-GalTs I and III expressed, which also possess a Lac-Cer synthase activity as shown by in vitro studies [23, 44] . Accordingly, amounts of Lac-Cer and its derivative gangliosides, mainly GM3, in the cells decreased significantly in B4galt5 −/− -derived MEF cells when compared with B4galt5 +/+ -and B4galt5 +/− -derived MEF cells, which is another strong evidence indicating that murine β-1,4-GalT V is substantially involved in the biosynthesis of Lac-Cer in the cells. In further support of this, human β-1,4-GalT V had a much higher specific activity of Lac-Cer synthesis than human β-1,4-GalT VI [30] . However, enzymes that are involved in Lac-Cer biosynthesis may differ among tissues and cell types since the gene expression patterns of the β-1,4-GalTs I, III, V and VI are different among species, tissues, cell types and developmental stages [20, 21, [23] [24] [25] 29] . Although human β-1,4-GalT V can galactosylate Nglycans in Sf-9 cells when its cDNA was transfected [28] , we failed to detect significant changes in ratios between galactosylated and ungalactosylated N-glycans in B4galt5 −/− -derived MEF cells by the two-dimensional mapping method [33] when compared to those of B4galt5 +/+ -and B4galt5 +/− -derived MEF cells. Since Oglycans were not expressed in MEF cells in sufficient amounts for their structural analysis, the involvement of murine β-1,4-GalT V in O-glycan biosynthesis was not established in the present study. These results indicate that murine β-1,4-GalT V is not involved in the galactosylation of N-glycans in mammalian cells although human β-1,4-GalT V can galactosylate N-and O-glycans in Sf-9 cells and in vitro, respectively [22, 28] . This discrepancy could come from the different localization of β-1,4-GalT V in Golgi-apparatus between Sf-9 cells and MEF cells, but not from a species difference between human and mouse since both enzymes share 95% identity at an amino acid level [29] . In this regard, we are currently investigating the fine localization of β-1,4-GalT V in Golgiapparatus using mouse tissues by immunocytochemical method. Our previous study showed that the growth of B4galt5 −/− -mouse embryos is severely retarded, and they are eliminated by E10.5, while B4galt5 +/− mice are born without any developmental defect [14] . However, little is known about the cause of death of B4galt5
-mouse embryos. Lactosylceramide plays a pivotal role as a precursor of nearly all major GSLs [19] . Previous studies showed that GSLs regulate signal transduction for cell proliferation, adhesion and migration, and by external stimuli [45] [46] [47] . GSLs clustered at cell surfaces interact with transmembrane proteins and cytoplasmic factors such as integrins, cadherin, growth factor receptors, tetraspanins, and non-receptor-type cytoplasmic protein kinases, and form glycosynaptic microdomains, which are supposed to control GSL-dependent/modulated cell adhesion, growth and motility of cells [48] [49] [50] through their associating proteins to bind to focal adhesion kinases, and cytoskeleton proteins including vinculin, talin and 51] . Quite interestingly, the fates of vinculin, talin, paxillin and pp125 focal adhesion kinaseknockout mice are similar, and they are eliminated by E8.5-E10.5 [52] [53] [54] [55] , at which stage B4galt5 −/− mice also die [14] . The Glc-Cer synthase and β-1,4-GalT V (Lac-Cer synthase)-knockout mice are embryonic lethal [11, 14] , while gene-knockout mice of ganglioside synthases and of globoseries GSL synthase are viable although they show impaired regeneration upon neural lesion, decreased nerve conduction velocity, age-associated axonal degeneration, and lethal audiogenic seizures [56] [57] [58] [59] [60] [61] . This indicates that Lac-Cer itself is important for the survival and activity of the embryos. In fact, Lac-Cer has been shown to activate an oxygen-sensitive signaling pathway involving superoxides, p21 RasGTP loading, and PI3 kinase/Akt activation, which ultimately contributes to changes in cell adhesion, migration and angiogenesis [reviewed in 19] . Therefore, the lack of Lac-Cer is a major reason why B4galt5 −/− mice die at a mid-gestation stage as we reported previously [14] .
